NCT00219323View on ClinicalTrials.gov

Long-Term Study of IGE025 in Moderate to Severe Bronchial Asthma.

PHASE3CompletedINTERVENTIONAL
Enrollment

133

Participants

Timeline

Start Date

November 30, 2003

Primary Completion Date

March 31, 2006

Study Completion Date

March 31, 2006

Conditions
Asthma
Interventions
DRUG

Omalizumab

Trial Locations (1)

Unknown

This study is not being conducted in the United States, Tokyo

Sponsors

Lead Sponsor

Novartis

Collaborators (1)

Daiichi Sankyo Co., Ltd.
All Listed Sponsors
collaborator

Daiichi Sankyo Co., Ltd.

INDUSTRY

lead

Novartis

INDUSTRY